United States · FDA National Drug Code directory
Fondaparinux Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-678_2a3f9c6b-885b-843d-9cc8-3eb67395fbda
- Product NDC
- 55111-678
- Form
- INJECTION
- Composition / generic term
- Fondaparinux Sodium
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110714
- Source listing expiry
- 20261231
Source-listed ingredients
- FONDAPARINUX SODIUM — 2.5 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (55111-678-02) / .5 mL in 1 SYRINGE (55111-678-11) · 55111-678-02
- 10 SYRINGE in 1 CARTON (55111-678-10) / .5 mL in 1 SYRINGE (55111-678-11) · 55111-678-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →